Bacterial complementation as a means to test enzyme-ligand interactions.
A bacterial complementation assay has been developed for the rapid screening of a large number of compounds to identify those that inhibit an enzyme target for structure-based inhibitor design. The target enzyme is the hypoxanthine phosphoribosyltransferase (HPRT). This enzyme has been proposed as a potential target for inhibitors that may be developed into drugs for the treatment of diseases caused by several parasites. The screening assay utilizes genetically deficient bacteria complemented by active, recombinant enzyme grown in selective medium in microtiter plates. By comparing absorbance measurements of bacteria grown in the presence and absence of test compounds, the effect of the compounds on bacterial growth can be rapidly assayed. IC50 values for inhibition of bacterial growth are a reflection of the ability of the compounds to bind and/or inhibit the recombinant enzyme. We have tested this bacterial complementation screening assay using recombinant HPRT from the parasites. Plasmodium falciparum and Trypanosoma cruzi, as well as the human enzyme. The results of these studies demonstrate that a screening assay using bacterial complement selection can be used to identify compounds that target enzymes and can become an important part of structure-based drug design efforts.
Laboratory of Molecular Parasitology and Drug Design, Division of Medicinal Chemistry and Natural Products, School of Pharmacy, University of North Carolina at Chapel Hill 27599-7360, USA.
B
B
Canyuk
S P
SP
Craig
A E
AE
Eakin
D000818:Animals; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D004926:Escherichia coli / Q000235:genetics / Q000254:growth & development*; D005816:Genetic Complementation Test; D005822:Genetic Vectors; D006801:Humans; D007041:Hypoxanthine Phosphoribosyltransferase / Q000037:antagonists & inhibitors* / Q000235:genetics* / Q000378:metabolism; D020128:Inhibitory Concentration 50; D008024:Ligands; D010963:Plasmodium falciparum / Q000201:enzymology / Q000235:genetics; D011687:Purines / Q000494:pharmacology*; D011994:Recombinant Proteins; D014349:Trypanosoma cruzi / Q000201:enzymology / Q000235:genetics
D004791:Enzyme Inhibitors; D008024:Ligands; D011687:Purines; D011994:Recombinant Proteins; D007041:Hypoxanthine Phosphoribosyltransferase